DEA: Marijuana-related generic drugs belong under Schedule III
Generic versions of Marinol should be classified as Schedule III when they are approved, according to the Drug Enforcement Administration
Because generic versions of Marinol (dronabinol, Solvay Pharmaceuticals) are in development, DEA is proposing to put these upcoming products that contain tetrahydrocannabinols (THC), when approved, under the same classification of Schedule III. THC is believed to be the major psychoactive component of the cannabis (marijuana) plant. This DEA proposal was published in the Sept. 24
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
